www.linkedin.com/pulse/gsk-ex...
GSK Expands Cancer Portfolio with $1.15B Acquisition of IDRx, Eyeing Breakthrough GIST Therapy
kstrategyand.com/pharma-news
#GSK #IDRx #GIST #CancerTreatment #CancerCare #HealthcareInnovation #MedicalBreakthrough #Humanteconomy #Humantec #KStrategyand
0
0
0
0